홈MCP워크벤치Skills
홈워크벤치알림마이페이지
Huagongshe 오픈 프로젝트:[email protected]AI 접속: llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.7.8
  1. 홈
  2. /화합물

에브로티딘

Ebrotidine

HCID 65869
노트반응
기본 정보개요이름 및 식별자물성안전 및 규제화학 및 산업관련 반응화합물 노트
부분 구조 검색유사 구조 찾기

기본 정보

CAS
100981-43-9
표준 SMILES
NC(N)=Nc1nc(CSCCN=CNS(=O)(=O)c2ccc(Br)cc2)cs1
InChIKey
ZQHFZHPUZXNPMF-UHFFFAOYSA-N
분자식
C14H17BrN6O2S3
평균 분자량
477.4 g/mol
단동위원소 질량
475.97585

개요

Ebrotidine is a sulfonamide.

이름 및 식별자

우선 이름
Ebrotidine
IUPAC
N-(4-bromophenyl)sulfonyl-N'-[2-[[2-(diaminomethylideneamino)-1,3-thiazol-4-yl]methylsulfanyl]ethyl]methanimidamide
현지명
에브로티딘
영어명
Ebrotidine
분자식
C14H17BrN6O2S3
분자량
477.42

이름 및 동의어

Ebrotidine100981-43-9EbrotidinaEbrotidinumTMZ3IBW2OWDTXSID801436014-bromo-N-(((2-(((-((diaminomethylene)amino)-4-thiazolyl)methyl)thio)ethyl)amino)methylene)benzenesulfonamideN-((4-bromobenzene)sulfonyl)-N'-(2-(((2-carbamimidamido-1,3-thiazol-4-yl)methyl)sulfanyl)ethyl)methanimidamideN-[(4-bromobenzene)sulfonyl]-N'-(2-{[(2-carbamimidamido-1,3-thiazol-4-yl)methyl]sulfanyl}ethyl)methanimidamideRefChem:136183DTXCID4066092FI-3542
이름 더 보기
에브로티딘FI3542UlsanicFI 3542Ebrotidine, 10 mM in DMSOFI 3542ULSANICFI3542Ebrotidine,FI 3542,Histamine Receptor,inhibit,Inhibitor,FI-3542(E)-N-[[[2-[[[2-[(Aminoiminomethyl)amino]-4-thiazolyl]methyl]thio]ethyl]amino]methylene]-4-bromobenzenesulfonamide
Ebrotidine [INN]N-(4-bromophenyl)sulfonyl-N'-[2-[[2-(diaminomethylideneamino)-1,3-thiazol-4-yl]methylsulfanyl]ethyl]methanimidamideEbrotiding(E)-N'-((4-bromophenyl)sulfonyl)-N-(2-(((2-guanidinothiazol-4-yl)methyl)thio)ethyl)formimidamideEbrotidinum [Latin]Ebrotidina [Spanish]Ebrocitp-Bromo-N-[(E)-({2-[({2-[(diaminomethylene)amino]-4-thiazolyl}methyl)thio]ethyl}amino)methylene]benzenesulfonamide;p-Bromo-N-[(E)-({2-[({2-[(diaminomethylene)amino]-4-thiazolyl}methyl)thio]ethyl}amino)methylene]benzenesulfonamide

물성

구조 계산 물성

XLogP
1.5
극성 표면적
198 Ų
수소 결합 공여자 수
3
수소 결합 수용자 수
7
회전 가능 결합 수
9
무거운 원자 수
26
형식 전하
0
복잡도
586

물리화학적 성질

녹는점
142.5 · 142.5-146℃
끓는 점
633 · 633.0±65.0 °C(Predicted)
밀도
1.73 · 1.73±0.1 g/cm3(Predicted)
저장 조건
-20 °C · Amber Vial, -20°C Freezer, Under inert atmosphere
용해도
DMSO(약간 용해됨), 메탄올(약간 용해됨)
산도 계수 (pKa)
5.25 · 5.25±0.40(Predicted)
물리적 상태
고체
색상
흰색에서 황백색까지
안정성
감광성

안전 및 규제

안전 정보는 참고용이며, 공급업체의 물질안전보건자료(SDS), 관련 법규 및 전문가 평가를 대체하지 않습니다.

독성 정보

Drug Induced Liver Injury · 6건

Drug Induced Liver Injury Rank (DILIrank 2.0)

Ebrotidine

vMost-DILI-concern

8

Withdrawn

DOI:10.1016/j.drudis.2016.02.015

화학 및 산업

약리 정보

MeSH Pharmacological Classification · 2건

Various agents with different action mechanisms used to treat or ameliorate PEPTIC ULCER or irritation of the gastrointestinal tract. This has included ANTIBIOTICS to treat HELICOBACTER INFECTIONS; HISTAMINE H2 ANTAGONISTS to reduce GASTRIC ACID secretion; and ANTACIDS for symptomatic relief.

Drugs that selectively bind to but do not activate histamine H2 receptors, thereby blocking the actions of histamine. Their clinically most important action is the inhibition of acid secretion in the treatment of gastrointestinal ulcers. Smooth muscle may also be affected. Some drugs in this class have strong effects in the central nervous system, but these actions are not well understood.

응용 분야 · 2건

개요Ebrocit was launched in Spain as a gastroprotective agent. It was prepared from 4-bromobenzenesulfonamide in two steps. Ebrocit's activity arises from its ability to antagonize histamine H2-receptors (the first of a new generation) showing 1.5-2.5 times higher affinity than Ranitidine and 2-fold greater affinity than cimetidine which correlates to an antisecretory potency of 1 times and 4-10 times respectively. Cytoand gastroprotection arises from increased gastric mucus production, enhanced physiochemical properties (decreased permeability of H+), and an increase in mucin glycosylation and sulfation. It acts on gastric mucosal EGF and PDGF receptor expression. Nitric oxide was also found to be involved. Ebrocit caused enhanced mucosal blood flow with anti H.pylori activity. It has diminished P450 binding which eliminates the possibility of mutagenic nitrosoamine formation.

용도Ebrotidine is a H2 receptor antagonist that has shown gastroprotective properties against gastric mucosal damange.

공급사29 곳

阿诺西(上海)生物技术有限公司400-1107768 15058188853 · [email protected]
Career Henan Chemica Co+86-0371-86658258 +86-13203830695 · [email protected]

관련 반응

0건
반응 기록 만들기

현재 필터 조건에 해당하는 반응 기록이 없습니다.

화합물 노트

불러오는 중…

이 페이지에서기본 정보개요이름 및 식별자물성안전 및 규제화학 및 산업관련 반응화합물 노트

데이터베이스 식별자

CAS
100981-43-9
PubChem CID
65869
DTXSID
DTXSID80143601
ChEMBL
CHEMBL1742471
ChEBI
CHEBI:135774
UNII
TMZ3IBW2OW
Nikkaji
J494.271J
杭州摩库生物医药科技有限公司+86-057181025280; +8617767106207 · [email protected]
Sinoway Industrial co., ltd.+86-0592-5800732 +86-13806035118 · [email protected]
Aladdin Scientific[email protected]
MedBio脉铂医药021-69568360 18916172912 · [email protected]
MedChemexpress LLC021-58955995 · [email protected]
AdooQ BioScience, LLC+1 (866) 930-6790 · [email protected]
天津普西唐生物医药科技有限公司010-60605840 · [email protected]
南京百鑫德诺生物科技有限公司025-58849295 · [email protected]
上海陶术生物科技股份有限公司+1-781-999-5354; +1-00000000000 · [email protected]
BOC Sciences16314854226; +8616314854226 · [email protected]
厦门志信化学有限公司+86-5922680277 +86-13806087780 · [email protected]
安耐吉化学&3A(安徽泽升科技股份有限公司)400-0056266 · [email protected]
艾吉析科技(上海)有限公司17717235263 17717235263 · [email protected]
广州市齐云生物技术有限公司020-61288194 61288195 · [email protected]
成都华纯科技有限公司400-1166-196 15982826727 · [email protected]
南京罗迈美生物科技有限公司[email protected]
爱必信(上海)生物科技有限公司13761418683 · [email protected]
武汉研哲科技有限公司15527250409 · [email protected]
Musechem+1-800-259-7612 · [email protected]
深圳聚合生化科技有限公司+86-400-002-6226 13028896684 · [email protected]
TargetMol中国(陶术生物)4008200310 15002144251 · [email protected]
ChemeGen 中国18818260767 · [email protected]
Mainchem Co., Ltd.+86-86-05926210733 · [email protected]
北京百灵威科技有限公司18210857532 18210857532 · [email protected]
上海皓元医药股份有限公司021-58950125 · [email protected]
南京世洲生物科技有限公司025-85560043 15850508050 · [email protected]
上海弘渠生物医药科技有限公司88888888888 · [email protected]